about
Risk of error estimated from Palestine pharmacists' knowledge and certainty on the adverse effects and contraindications of active pharmaceutical ingredients and excipientsElectronic prescribing reduces prescribing error in public hospitals.Palestinian pharmacists' knowledge of issues related to using psychotropic medications in older people: a cross-sectional study.The recombinant vaccinia virus gene product, B18R, neutralizes interferon alpha and alleviates histopathological complications in an HIV encephalitis mouse modelWhich Benefits and Harms of Using Fenugreek as a Galactogogue Need to Be Discussed during Clinical Consultations? A Delphi Study among Breastfeeding Women, Gynecologists, Pediatricians, Family Physicians, Lactation Consultants, and Pharmacists.Combining and Using the Utrecht Method and the Analytic Hierarchy Process to Facilitate Professional and Ethical Deliberation and Decision Making in Complementary and Alternative Medicine: A Case Study among a Panel of StakeholdersWhat Do Primary Healthcare Providers and Complementary and Alternative Medicine Practitioners in Palestine Need to Know about Exercise for Cancer Patients and Survivors: A Consensual Study Using the Delphi TechniquePharmacokinetic simulations to explore dissolution criteria of BCS I and III biowaivers with and without MDR-1 efflux transporterMerits, features, and desiderata to be considered when developing electronic health records with embedded clinical decision support systems in Palestinian hospitals: a consensus studyQuality Indicators of Pharmaceutical Care for Integrative Healthcare: A Scoping Review of Indicators Developed Using the Delphi TechniqueMedication transcription errors in hospitalized patient settings: a consensual study in the Palestinian nursing practiceQuality Indicators of Pharmaceutical Care in Palestinian Integrative Healthcare Facilities: Findings of a Qualitative Study among Stakeholders
P50
Q27332334-DFFD4032-BADE-4752-B400-775422E97EF6Q37882758-29DB9B46-BE15-4A34-AC95-C559B8C719D1Q41313524-263A1935-7F01-4A40-8DD5-3C8516694032Q42235552-F6E169A0-B7BA-4E15-9F84-33C34836E731Q55193246-3F005413-9076-4252-AA23-B388D8B8329EQ60935531-474645D9-F9FD-4008-89C6-2A45BC0EB597Q64104829-422ACE8A-2D3C-472E-8FB6-4216CD334673Q87353619-9027CA2A-4381-4694-8748-2AFCD82E4583Q91192516-DCECC5E3-6B64-4E07-BF80-496F0FFA6CA6Q91638301-A0DD18EB-8A14-48C1-8539-6CA9EB380921Q93157585-0D959859-20AF-4D2B-9578-8C21C4320F5DQ95855660-9123A532-68F0-4888-85EE-680225AE4080
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ramzi Shawahna
@en
Ramzi Shawahna
@nl
type
label
Ramzi Shawahna
@en
Ramzi Shawahna
@nl
prefLabel
Ramzi Shawahna
@en
Ramzi Shawahna
@nl
P31
P496
0000-0002-2403-610X